medigraphic.com

2013, Number 2

<< Back Next >>

Cir Cir 2013; 81 (2)

Study of 14 cases of breast cancer and pregnancy

Vargas-Hernandez VM, Garcia-Rodriguez FM, Jiménez-Villanueva X, Hernandez-Rubio Á, Aboharp-Hassan Z, Moreno-Eutimio MA

Language: Spanish
References: 21
Page: 108-111
PDF size: 976.93 Kb.


ABSTRACT

Introduction: Breast cancer is diagnosed in pregnant women during pregnancy or the first year after childbirth, and is the second leading cause of death among women of reproductive age. In the Juarez Hospital of Mexico are unknown frequency of this disease and the characteristics of the women affected. This paper analyzed the cases of pregnant women diagnosed with breast cancer, treated the Oncology Department over a period of 10 years (1990-2000).
Methods: We performed a retrospective descriptive study of pregnant women diagnosed with breast cancer, treated at. Of the cases found, the following indicators were studied: maternal age, type of cancer, and weeks of gestation at the time of diagnosis, resolution of pregnancy and perinatal outcome, and treatment monitoring. Descriptive statistics were performed using measures of central tendency and dispersion.
Results: There were 14 cases of pregnant women with breast cancer. The mean age of patients was 28 years, with a mean of 23 weeks gestation at diagnosis. The resolution of pregnancy was favorable in 73% of cases. The 78.6% of the patients were treated, 72.7% had follow-up for 2 years, found 62.5% of patients without tumor activity.
Conclusions: The frequency of pregnant women with breast cancer is low, affecting young people. The choice of treatment allowed the resolution of pregnancy and survival of women without tumor activity.


REFERENCES

  1. Hickey M, Peate M, Saunders CM, Friedlander M. Breast cancer in young women and its impact on reproductive function. Hum Reprod Update 2009;15(3):323-339.

  2. Vargas-Hernández VM, Hernandez Rubio A, Coronel Cruz F. Tumores mamarios durante el embarazo en Cáncer en la Mujer. En Vargas-Hernández VM, editor. Cáncer en la Mujer, Edit. Alfil, México, 2011 p. 1239-1250.

  3. Navrozoglou I, Vrekoussis T, Kontostolis E, Dousias V, Zervoudis S, Stathopoulos EN, et al. Breast cancer during pregnancy: A minireview. Eur J Surg Oncol 2008;34(8):837-843.

  4. Ring A, Smith IE, Ellis PA. Breast Cancer and Pregnancy. Ann Oncol 2005;16(12):1855-1860.

  5. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 2005;117(6):988- 991.

  6. Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, et al. Breast carcinoma during pregnancy: International recommendations from an expert meeting. Cancer 2006;106(2):237-246.

  7. Psyrri A, Burtness B. Pregnancy-Associated Breast Cancer. Cancer J 2005;11(2):83-95.

  8. Gallegos-Hernandez JF. Abordaje diagnóstico-terapéutico del cáncer de mama asociado con embarazo. Actualización 2010. Cir Cir 2010;78(3):273-282.

  9. Partridge A, Schapira L. Pregnancy and breast cancer: epidemiology, treatment, and safety issues. Oncology 2005;19(6):693-697.

  10. Barthelmes L, Davidson LA, Gaffney C, Gateley CA. Pregnancy and breast cancer. BMJ 2005;330(7504):1375-1378.

  11. Largent JA, Ziogas A, Anton-Culver H. Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res 2005;7(4):R541-554.

  12. Son EJ, Oh KK, Kim EK. Pregnancy–Associated Breast Disease: Radiologic Features and Diagnostic Dilemmas. Yousei Medical J 2006;47(1):34-42.

  13. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching Hospitals. J Clin Oncol 2005;23(18):4192-4197.

  14. Lenhard MS, Bauerfeind I, Untch M. Breast cancer and pregnancy: Challenges of chemotherapy Crit Rev Oncol Hematol 2008;67(3):196-203.

  15. Vargas-Hernandez VM, Alvarado SC. Quimioterapia durante el embarazo en Cáncer en la Mujer. En Vargas-Hernández VM, editor. Cáncer en la Mujer, Edit. Alfil, 2011 México.

  16. Cardonick E, Lacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5(5):283-291.

  17. Gentilini O, Cremonesi M, Trifirò G, Ferrari M, Baio SM, Caracciolo M, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15(9):1348-1351.

  18. León-Villalba JC, López-Granel CM, Lara-Medina F, Calderón G, Chanona-Vilchis J, Solorza-Luna G. Cáncer y embarazo: experiencia en el Instituto Nacional de Cancerología de México. Rev Inst Nal Cancerol Mex 1999;45(3):144-152.

  19. Cortés VC, Belmar NN, Domínguez CF, Álvarez ZM, Oddo BD, Oyarzún EE. Caso clínico: Cáncer de mama y embarazo. Bol Esc Med U.C. Pontificia Universidad Autónoma de Chile 2008;33(1):64-67.

  20. Consenso Nacional de Diagnóstico y Tratamiento del Cáncer de Mama, Colima 2011. Cáncer de mama durante el embarazo y la lactancia. Gaceta Mex Oncol 2011;10(Supl 5):41.

  21. Robles-Castillo J, Ruvalcaba-Limón E, Maffuz A, Rodríguez- Cuevas S. Cáncer de mama en mujeres mexicanas menores de 40 años. Ginecol Obstet Mex 2011;79(8):482-488.




2020     |     www.medigraphic.com